These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37295035)

  • 21. Hybrid Immunity to SARS-CoV-2 During Pregnancy Provides More Durable Infant Antibody Responses Compared to Natural Infection Alone.
    LaCourse SM; Wetzler EA; Aurelio MC; Escudero JN; Selke SS; Greninger AL; Goecker EA; Barnes SR; Arnould IS; Pérez-Osorio AC; Richardson BA; Kachikis A; Englund JA; Drake AL
    J Infect Dis; 2024 Jun; 229(6):1728-1739. PubMed ID: 38128542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maternal and Cord Anti-SARS-CoV-2-Spike IgG following COVID-19 Vaccination versus Infection during Pregnancy: A Prospective Study, Israel October 2021-March 2022.
    Abu Shqara R; Frank Wolf M; Mikhail Mustafa S; Sgayer I; Assulyn T; Abu Zraki A; Askhar Majadla N; Rechnizter H; Shehadeh M; Fleisher Sheffer V; Bordeynik-Cohen M; Yakir O; Lowenstein L; Sela E; Edelstein M; Dror AA
    Am J Perinatol; 2024 May; 41(S 01):e1935-e1943. PubMed ID: 37164317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SARS-CoV-2 anti-RBD and anti-N protein responses are differentially regulated between mother-child pairs: insight from a national study cohort at the Faroe Islands.
    Jarlhelt I; Hansen CB; Pérez-Alós L; Weihe P; Petersen MS; Garred P
    Front Immunol; 2024; 15():1418678. PubMed ID: 39021574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maternal-infant transfer of SARS-CoV-2 antibodies following vaccination in pregnancy: A prospective cohort study.
    Korchinski I; Marquez C; McClymont E; Av-Gay G; Andrade J; Elwood C; Jassem A; Krajden M; Morshed M; Sadarangani M; Tanunliong G; Sekirov I; Money D
    Vaccine; 2024 Nov; 42(25):126123. PubMed ID: 38981741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of Maternal Perinatal SARS-CoV-2 Infection With Neonatal Outcomes During the COVID-19 Pandemic in Massachusetts.
    Angelidou A; Sullivan K; Melvin PR; Shui JE; Goldfarb IT; Bartolome R; Chaudhary N; Vaidya R; Culic I; Singh R; Yanni D; Patrizi S; Hudak ML; Parker MG; Belfort MB
    JAMA Netw Open; 2021 Apr; 4(4):e217523. PubMed ID: 33890989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccination in twin pregnancies: comparison between immunization before conception and during pregnancy.
    Svirsky R; Rabbi ML; Hamad RA; Sharabi-Nov A; Kugler N; Galoyan N; Sharon NZ; Meiri H; Maymon R; Levtzion-Korach O
    Sci Rep; 2024 May; 14(1):10813. PubMed ID: 38734805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maternal and neonatal immune response to SARS-CoV-2, IgG transplacental transfer and cytokine profile.
    Rubio R; Aguilar R; Bustamante M; Muñoz E; Vázquez-Santiago M; Santano R; Vidal M; Melero NR; Parras D; Serra P; Santamaria P; Carolis C; Izquierdo L; Gómez-Roig MD; Dobaño C; Moncunill G; Mazarico E
    Front Immunol; 2022; 13():999136. PubMed ID: 36238312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Effect of Gestational Age at BNT162b2 mRNA Vaccination on Maternal and Neonatal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Levels.
    Rottenstreich A; Zarbiv G; Oiknine-Djian E; Vorontsov O; Zigron R; Kleinstern G; Wolf DG; Porat S
    Clin Infect Dis; 2022 Aug; 75(1):e603-e610. PubMed ID: 35171998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of the transplacental transmission of SARS CoV-2 virus and antibody transfer according to the gestational age at maternal infection.
    Lucot-Royer L; Nallet C; Vouga M; Puyraveau M; Mauny F; Marty-Quinternet S; Bertholdt C; Bory JP; Devalland C; Canaguier M; Copolla C; Eszto ML; Montoya Y; Roesch M; Reviron S; Riethmuller D; Rufenacht E; Simon E; Mottet N
    Sci Rep; 2024 Feb; 14(1):3458. PubMed ID: 38342940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Longitudinal analysis of antibody response following SARS-CoV-2 infection in pregnancy: From the first trimester to delivery.
    Cosma S; Carosso AR; Corcione S; Cusato J; Borella F; Antonucci M; Marozio L; Revelli A; Preti M; Ghisetti V; Di Perri G; Benedetto C
    J Reprod Immunol; 2021 Apr; 144():103285. PubMed ID: 33582489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of Gestational Age at Coronavirus Disease 2019 (COVID-19) Vaccination, History of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, and a Vaccine Booster Dose With Maternal and Umbilical Cord Antibody Levels at Delivery.
    Yang YJ; Murphy EA; Singh S; Sukhu AC; Wolfe I; Adurty S; Eng D; Yee J; Mohammed I; Zhao Z; Riley LE; Prabhu M
    Obstet Gynecol; 2022 Mar; 139(3):373-380. PubMed ID: 34963127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors Associated with Neutralizing Antibody Responses following 2-Dose and 3rd Booster Monovalent COVID-19 Vaccination in Japanese People Living with HIV.
    Ngare I; Tan TS; Toyoda M; Kuwata T; Takahama S; Nakashima E; Yamasaki N; Motozono C; Fujii T; Minami R; Barabona G; Ueno T
    Viruses; 2024 Apr; 16(4):. PubMed ID: 38675897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of Anti-SARS-CoV-2-specific IgG Levels in Breast Milk after Vaccination or COVID-19 Infection.
    Temocin F; Çaycı YT; Seren C; Kuruoglu T; Atilla A; Birinci A; Tanyel E
    Am J Perinatol; 2024 May; 41(S 01):e3085-e3090. PubMed ID: 37846474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 18-month longitudinal SARS COV-2 neutralizing antibody dynamics in haemodialysis patients receiving heterologous 3-dose vaccination (AZD-1222- AZD-1222- BNT162b2) in a lower middle income setting.
    Karunathilake RP; Kumara RA; Karunathilaka A; Wazil AWM; Nanayakkara N; Bandara CK; Abeysekera RA; Noordeen F; Gawarammana IB; Ratnatunga CN
    BMC Nephrol; 2024 May; 25(1):176. PubMed ID: 38778281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity.
    Legros V; Denolly S; Vogrig M; Boson B; Siret E; Rigaill J; Pillet S; Grattard F; Gonzalo S; Verhoeven P; Allatif O; Berthelot P; Pélissier C; Thiery G; Botelho-Nevers E; Millet G; Morel J; Paul S; Walzer T; Cosset FL; Bourlet T; Pozzetto B
    Cell Mol Immunol; 2021 Feb; 18(2):318-327. PubMed ID: 33408342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maternal antibody transfer rate of vaccination against SARS-CoV-2 before or during early pregnancy and its protective effectiveness on offspring.
    Liu S; Wang P; Shi X; Weng T; Zhong J; Zhang X; Qu J; Chen L; Xu Q; Meng X; Xiong H; Wu D; Fang D; Peng B; Zhang D
    J Med Virol; 2023 Oct; 95(10):e29125. PubMed ID: 37800607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Global Perspectives on Immunization Against SARS-CoV-2 During Pregnancy and Priorities for Future Research: An International Consensus Paper From the World Association of Infectious Diseases and Immunological Disorders.
    Abu-Raya B; Madhi SA; Omer SB; Amirthalingam G; Giles ML; Flanagan KL; Zimmermann P; O'Ryan M; Safadi MA; Papaevangelou V; Maertens K; Wanlapakorn N; Diaz-Brito V; Tommelein E; Esposito S
    Front Immunol; 2021; 12():808064. PubMed ID: 35003137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of Anti-SARS-CoV-2-Specific Antibody Signatures in Maternal and Infant Blood after COVID-19 Infection versus COVID-19 Vaccination during Pregnancy.
    Sabharwal V; Taglauer E; Demos R; Snyder-Cappione J; Shaik-Dasthagirisaheb YB; Parker-Kelleher S; Hunnewell J; Boateng J; Clarke K; Yuen R; Barnett ED; Wachman EM; Yarrington CD
    Am J Perinatol; 2024 May; 41(S 01):e2970-e2977. PubMed ID: 37774748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maternal Antibody Response, Neutralizing Potency, and Placental Antibody Transfer After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.
    Joseph NT; Dude CM; Verkerke HP; Irby LS; Dunlop AL; Patel RM; Easley KA; Smith AK; Stowell SR; Jamieson DJ; Velu V; Badell ML
    Obstet Gynecol; 2021 Aug; 138(2):189-197. PubMed ID: 33910220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID-19 mRNA Vaccination in Lactation: Assessment of Adverse Events and Vaccine Related Antibodies in Mother-Infant Dyads.
    Golan Y; Prahl M; Cassidy AG; Gay C; Wu AHB; Jigmeddagva U; Lin CY; Gonzalez VJ; Basilio E; Chidboy MA; Warrier L; Buarpung S; Li L; Murtha AP; Asiodu IV; Ahituv N; Flaherman VJ; Gaw SL
    Front Immunol; 2021; 12():777103. PubMed ID: 34804068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.